Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease.

Rufaihah AJ, Huang NF, Jamé S, Lee JC, Nguyen HN, Byers B, De A, Okogbaa J, Rollins M, Reijo-Pera R, Gambhir SS, Cooke JP.

Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):e72-9. doi: 10.1161/ATVBAHA.111.230938.

2.

MicroRNA regulation of endothelial homeostasis and commitment-implications for vascular regeneration strategies using stem cell therapies.

Scott E, Loya K, Mountford J, Milligan G, Baker AH.

Free Radic Biol Med. 2013 Sep;64:52-60. doi: 10.1016/j.freeradbiomed.2013.04.037. Epub 2013 May 9. Review.

3.

Development of pluripotent stem cells for vascular therapy.

Volz KS, Miljan E, Khoo A, Cooke JP.

Vascul Pharmacol. 2012 May-Jun;56(5-6):288-96. doi: 10.1016/j.vph.2012.02.010. Epub 2012 Feb 23. Review.

4.

Angiogenic cell therapy for critical limb ischemia: an update on concepts and trials.

Furmston J, Patel AS, Ludwinski F, Zuzel V, Bajwa A, Saha P, Smith A, Modarai B.

J Cardiovasc Surg (Torino). 2014 Oct;55(5):641-54. Epub 2014 Jun 18. Review.

PMID:
24941243
5.

Cell therapy of peripheral arterial disease: from experimental findings to clinical trials.

Raval Z, Losordo DW.

Circ Res. 2013 Apr 26;112(9):1288-302. doi: 10.1161/CIRCRESAHA.113.300565. Review.

6.

Mesenchymal stem cells as a treatment for peripheral arterial disease: current status and potential impact of type II diabetes on their therapeutic efficacy.

Yan J, Tie G, Xu TY, Cecchini K, Messina LM.

Stem Cell Rev. 2013 Jun;9(3):360-72. doi: 10.1007/s12015-013-9433-8. Review.

7.

Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease.

Hou L, Kim JJ, Woo YJ, Huang NF.

Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H455-65. doi: 10.1152/ajpheart.00726.2015. Epub 2015 Dec 18. Review.

8.

Imaging stem cell therapy for the treatment of peripheral arterial disease.

Ransohoff JD, Wu JC.

Curr Vasc Pharmacol. 2012 May;10(3):361-73. Review.

9.

Therapeutic revascularisation of ischaemic tissue: the opportunities and challenges for therapy using vascular stem/progenitor cells.

O'Neill CL, O'Doherty MT, Wilson SE, Rana AA, Hirst CE, Stitt AW, Medina RJ.

Stem Cell Res Ther. 2012 Aug 16;3(4):31. doi: 10.1186/scrt122. Review.

10.

Clinical trials of adult stem cell therapy for peripheral artery disease.

Botham CM, Bennett WL, Cooke JP.

Methodist Debakey Cardiovasc J. 2013 Oct-Dec;9(4):201-5. Review. Erratum in: Methodist Debakey Cardiovasc J. 2014 Apr-Jun;10(2):134.

11.

Endothelial cells derived from nuclear reprogramming.

Wong WT, Huang NF, Botham CM, Sayed N, Cooke JP.

Circ Res. 2012 Oct 26;111(10):1363-75. doi: 10.1161/CIRCRESAHA.111.247213. Review.

12.

Phenotypic overlap between monocytes and vascular endothelial cells.

Schmeisser A, Graffy C, Daniel WG, Strasser RH.

Adv Exp Med Biol. 2003;522:59-74. Review.

PMID:
12674211
13.

Concise review: tissue-specific microvascular endothelial cells derived from human pluripotent stem cells.

Wilson HK, Canfield SG, Shusta EV, Palecek SP.

Stem Cells. 2014 Dec;32(12):3037-45. doi: 10.1002/stem.1797. Review.

14.

From bench to bedside: review of gene and cell-based therapies and the slow advancement into phase 3 clinical trials, with a focus on Aastrom's Ixmyelocel-T.

Bartel RL, Booth E, Cramer C, Ledford K, Watling S, Zeigler F.

Stem Cell Rev. 2013 Jun;9(3):373-83. doi: 10.1007/s12015-013-9431-x. Review.

15.

Targets and delivery methods for therapeutic angiogenesis in peripheral artery disease.

Ouma GO, Jonas RA, Usman MH, Mohler ER 3rd.

Vasc Med. 2012 Jun;17(3):174-92. doi: 10.1177/1358863X12438270. Epub 2012 Apr 11. Review.

16.

[Cell therapy of critical lower limb ischemia (problems and prospects)].

Lebedev SV, Karasev AV, Kungurtsev VV, Lokhonina AV, Kleń≠menova EB.

Vestn Ross Akad Med Nauk. 2013;(3):33-44. Review. Russian.

PMID:
23808268
17.
18.

Imaging techniques to evaluate cell therapy in peripheral artery disease: state of the art and clinical trials.

Grimaldi V, Schiano C, Casamassimi A, Zullo A, Soricelli A, Mancini FP, Napoli C.

Clin Physiol Funct Imaging. 2016 May;36(3):165-78. doi: 10.1111/cpf.12210. Epub 2014 Nov 11. Review.

PMID:
25385089
19.

Defining the potential for cell therapy for vascular disease using animal models.

Gulati R, Simari RD.

Dis Model Mech. 2009 Mar-Apr;2(3-4):130-7. doi: 10.1242/dmm.000562. Review.

Supplemental Content

Support Center